About this item:

61 Views | 58 Downloads

Author Notes:

Jing Sui, State Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University, Beijing, 100875, China. Email: jsui@bnu.edu.cn

Sha Liu, Department of Psychiatry, First Clinical Medical College/ First Hospital of Shanxi Medical University, Taiyuan 030000, China. Email: liusha@sxmu.edu.cn

This work was supported by the National Key Research and Development Program of China(2017YFA0105203), the National Natural Sciences Foundation of China (82022035, 82001450, 81701326, 61773380), China Postdoctoral Science Foundation (BX20200364), Shanxi Provincial Science and Technology achievements transformation and guidance project (201904D131020), Special Project of Scientific Research Plan Talents of Shanxi Provincial Health Commission (2020081), Shanxi Province Overseas Students Science and Technology Activity Funding Project (20200038), the National Institute of Health (R01MH117107, P20GM103472, and P30GM122734), and the National Science Foundation (1539067, 2112455).

The authors report no biomedical financial interests or potential conflicts of interest.

Subject:

Research Funding:

The National Key Research and Development Program of China, Grant/Award Number: 2017YFA0105203; National Natural Sciences Foundation of China, Grant/Award Numbers: 82022035, 61773380, 82001450, 81701326; China Postdoctoral Science Foundation, Grant/Award Number: BX20200364; the National Institute of Health, Grant/Award Numbers: R01MH117107, P20GM103472, P30GM122734; Shanxi Provincial Science and Technology achievements transformation and guidance project, Grant/Award Number: 201904D131020; Special Project of Scientific Research Plan Talents of Shanxi Provincial Health Commission, Grant/Award Number: 2020081; Shanxi Province Overseas Students Science and Technology Activity Funding Project, Grant/Award Number: 20200038; the National Science Foundation, Grant/Award Numbers: 1539067, 2112455

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Neurosciences
  • Neuroimaging
  • Radiology, Nuclear Medicine & Medical Imaging
  • Neurosciences & Neurology
  • early-onset schizophrenia (EOS)
  • MRI
  • multimodal fusion
  • PANSS
  • symptom prediction
  • ANTERIOR CINGULATE CORTEX
  • FUNCTIONAL CONNECTIVITY
  • DEFAULT-MODE
  • 1ST-EPISODE SCHIZOPHRENIA
  • ANTIPSYCHOTIC TREATMENT
  • NETWORK
  • FMRI
  • ABNORMALITIES
  • STRIATUM
  • GREY

Multimodal brain deficits shared in early-onset and adult-onset schizophrenia predict positive symptoms regardless of illness stage

Show all authors Show less authors

Tools:

Journal Title:

HUMAN BRAIN MAPPING

Volume:

Volume 43, Number 11

Publisher:

, Pages 3486-3497

Type of Work:

Article | Final Publisher PDF

Abstract:

Incidence of schizophrenia (SZ) has two predominant peaks, in adolescent and young adult. Early-onset schizophrenia provides an opportunity to explore the neuropathology of SZ early in the disorder and without the confound of antipsychotic mediation. However, it remains unexplored what deficits are shared or differ between adolescent early-onset (EOS) and adult-onset schizophrenia (AOS) patients. Here, based on 529 participants recruited from three independent cohorts, we explored AOS and EOS common and unique co-varying patterns by jointly analyzing three MRI features: fractional amplitude of low-frequency fluctuations (fALFF), gray matter (GM), and functional network connectivity (FNC). Furthermore, a prediction model was built to evaluate whether the common deficits in drug-naive SZ could be replicated in chronic patients. Results demonstrated that (1) both EOS and AOS patients showed decreased fALFF and GM in default mode network, increased fALFF and GM in the sub-cortical network, and aberrant FNC primarily related to middle temporal gyrus; (2) the commonly identified regions in drug-naive SZ correlate with PANSS positive significantly, which can also predict PANSS positive in chronic SZ with longer duration of illness. Collectively, results suggest that multimodal imaging signatures shared by two types of drug-naive SZ are also associated with positive symptom severity in chronic SZ and may be vital for understanding the progressive schizophrenic brain structural and functional deficits.

Copyright information:

© 2022 The Authors. Human Brain Mapping published by Wiley Periodicals LLC.

This is an Open Access work distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/rdf).
Export to EndNote